Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Apoptosis regulator Bcl-2

 BCL2_MOUSE              Reviewed;         236 AA.
P10417; P10418; Q4VBF6;
01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
03-OCT-2012, sequence version 3.
05-DEC-2018, entry version 196.
RecName: Full=Apoptosis regulator Bcl-2;
Name=Bcl2; Synonyms=Bcl-2;
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
PubMed=3032455; DOI=10.1016/0092-8674(87)90448-X;
Negrini M., Silini E., Kozak C., Tsujimoto Y., Croce C.M.;
"Molecular analysis of mbcl-2: structure and expression of the murine
gene homologous to the human gene involved in follicular lymphoma.";
Cell 49:455-463(1987).
PubMed=1508712; DOI=10.1093/nar/20.16.4187;
Eguchi Y., Ewert D.L., Tsujimoto Y.;
"Isolation and characterization of the chicken bcl-2 gene: expression
in a variety of tissues including lymphoid and neuronal organs in
adult and embryo.";
Nucleic Acids Res. 20:4187-4192(1992).
PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
Lindblad-Toh K., Eichler E.E., Ponting C.P.;
"Lineage-specific biology revealed by a finished genome assembly of
the mouse.";
PLoS Biol. 7:E1000112-E1000112(2009).
Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
TISSUE=Olfactory epithelium;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
PubMed=9115213; DOI=10.1074/jbc.272.18.11671;
Ito T., Deng X., Carr B., May W.S. Jr.;
"Bcl-2 phosphorylation required for anti-apoptosis function.";
J. Biol. Chem. 272:11671-11673(1997).
PubMed=9852076; DOI=10.1074/jbc.273.51.34157;
Deng X., Ito T., Carr B., Mumby M., May W.S. Jr.;
"Reversible phosphorylation of Bcl2 following interleukin 3 or
bryostatin 1 is mediated by direct interaction with protein
phosphatase 2A.";
J. Biol. Chem. 273:34157-34163(1998).
PubMed=15781622; DOI=10.1158/0008-5472.CAN-04-3377;
Zhao X., Ayer R.E., Davis S.L., Ames S.J., Florence B., Torchinsky C.,
Liou J.S., Shen L., Spanjaard R.A.;
"Apoptosis factor EI24/PIG8 is a novel endoplasmic reticulum-localized
Bcl-2-binding protein which is associated with suppression of breast
cancer invasiveness.";
Cancer Res. 65:2125-2129(2005).
PubMed=17418785; DOI=10.1016/j.cell.2007.01.045;
Bruey J.M., Bruey-Sedano N., Luciano F., Zhai D., Balpai R., Xu C.,
Kress C.L., Bailly-Maitre B., Li X., Osterman A., Matsuzawa S.,
Terskikh A.V., Faustin B., Reed J.C.;
"Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by
interaction with NALP1.";
Cell 129:45-56(2007).
TISSUE=Lung, and Spleen;
PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
"A tissue-specific atlas of mouse protein phosphorylation and
Cell 143:1174-1189(2010).
-!- FUNCTION: Suppresses apoptosis in a variety of cell systems
including factor-dependent lymphohematopoietic and neural cells.
Regulates cell death by controlling the mitochondrial membrane
permeability. Appears to function in a feedback loop system with
caspases. Inhibits caspase activity either by preventing the
release of cytochrome c from the mitochondria and/or by binding to
the apoptosis-activating factor (APAF-1). May attenuate
inflammation by impairing NLRP1-inflammasome activation, hence
CASP1 activation and IL1B release (PubMed:17418785).
-!- SUBUNIT: Forms homodimers, and heterodimers with BAX, BAD, BAK and
Bcl-X(L). Heterodimerization with BAX requires intact BH1 and BH2
motifs, and is necessary for anti-apoptotic activity (By
similarity). Also interacts with APAF1, BBC3, BCL2L1, BNIPL,
MRPL41 and TP53BP2. Binding to FKBP8 seems to target BCL2 to the
mitochondria and probably interferes with the binding of BCL2 to
its targets. Interacts with BAG1 in an ATP-dependent manner.
Interacts with RAF1 (the 'Ser-338' and 'Ser-339' phosphorylated
form). Interacts (via the BH4 domain) with EGLN3; the interaction
prevents the formation of the BAX-BCL2 complex and inhibits the
anti-apoptotic activity of BCL2 (By similarity). Interacts with
EI24. Interacts with G0S2; this interaction also prevents the
formation of the anti-apoptotic BAX-BCL2 complex. Interacts with
PPIF; the interaction is impaired by CsA (By similarity).
Interacts with BOP (By similarity). Interacts with the SCF(FBXO10)
complex (By similarity). Interacts (via the loop between motifs
BH4 and BH3) with NLRP1 (via LRR repeats) (By similarity).
{ECO:0000250, ECO:0000250|UniProtKB:P10415}.
Q07813:Bax; NbExp=2; IntAct=EBI-526314, EBI-700711;
O54918-1:Bcl2l11; NbExp=2; IntAct=EBI-526314, EBI-526076;
O88597:Becn1; NbExp=11; IntAct=EBI-526314, EBI-643716;
Q99MI6:Gimap3; NbExp=4; IntAct=EBI-526314, EBI-15572304;
Q8BWF2:Gimap5; NbExp=3; IntAct=EBI-526314, EBI-15572348;
-!- SUBCELLULAR LOCATION: Mitochondrion outer membrane; Single-pass
membrane protein. Nucleus membrane; Single-pass membrane protein.
Endoplasmic reticulum membrane; Single-pass membrane protein.
Event=Alternative splicing; Named isoforms=2;
IsoId=P10417-1; Sequence=Displayed;
IsoId=P10417-2; Sequence=VSP_000513;
-!- TISSUE SPECIFICITY: Expressed in a variety of tissues.
-!- DOMAIN: The BH4 motif is required for anti-apoptotic activity and
for interaction with RAF1 and EGLN3.
-!- DOMAIN: BH1 and BH2 domains are required for the interaction with
BAX and for anti-apoptotic activity.
-!- DOMAIN: The loop between motifs BH4 and BH3 is required for the
interaction with NLRP1. {ECO:0000250|UniProtKB:P10415}.
-!- PTM: Phosphorylation/dephosphorylation on Ser-70 regulates anti-
apoptotic activity. Growth factor-stimulated phosphorylation on
Ser-70 by PKC is required for the anti-apoptosis activity and
occurs during the G2/M phase of the cell cycle. In the absence of
growth factors, BCL2 appears to be phosphorylated by other protein
kinases such as ERKs and stress-activated kinases. Phosphorylated
by MAPK8/JNK1 at Thr-69, Ser-70 and Ser-84, wich stimulates
starvation-induced autophagy (By similarity). Dephosphorylated by
protein phosphatase 2A (PP2A). {ECO:0000250,
-!- PTM: Proteolytically cleaved by caspases during apoptosis. The
cleaved protein, lacking the BH4 motif, has pro-apoptotic
activity, causes the release of cytochrome c into the cytosol
promoting further caspase activity.
-!- PTM: Monoubiquitinated by PRKN, leading to increase its stability.
Ubiquitinated by SCF(FBXO10), leading to its degradation by the
proteasome. {ECO:0000250}.
-!- DISRUPTION PHENOTYPE: In response to intraperitoneal injection of
muramyl dipeptide (MDP), knockout animals show lower serum IL1B
levels than wild type. Mutant macrophages release 30% less IL1B
than the wild-type cells. {ECO:0000269|PubMed:17418785}.
-!- SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
EMBL; L31532; AAA37282.1; -; Genomic_DNA.
EMBL; M16506; AAA37282.1; JOINED; Genomic_DNA.
EMBL; M16506; AAA37281.1; -; Genomic_DNA.
EMBL; AC122842; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AC162916; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH466520; EDL39862.1; -; Genomic_DNA.
EMBL; BC095964; AAH95964.1; -; mRNA.
CCDS; CCDS15209.1; -. [P10417-1]
CCDS; CCDS78667.1; -. [P10417-2]
PIR; A25960; TVMSA1.
PIR; B25960; TVMSB1.
RefSeq; NP_033871.2; NM_009741.5. [P10417-1]
UniGene; Mm.257460; -.
ProteinModelPortal; P10417; -.
SMR; P10417; -.
BioGrid; 198318; 32.
ComplexPortal; CPX-2017; BCL-2 dimer.
ComplexPortal; CPX-2019; BAD:BCL-2 complex.
ComplexPortal; CPX-2024; BID:BCL-2 complex.
ComplexPortal; CPX-2027; PUMA:BCL-2 complex.
ComplexPortal; CPX-2036; BIM:BCL-2 complex.
CORUM; P10417; -.
DIP; DIP-1065N; -.
IntAct; P10417; 10.
MINT; P10417; -.
STRING; 10090.ENSMUSP00000108371; -.
BindingDB; P10417; -.
ChEMBL; CHEMBL3309111; -.
iPTMnet; P10417; -.
PhosphoSitePlus; P10417; -.
PaxDb; P10417; -.
PeptideAtlas; P10417; -.
PRIDE; P10417; -.
Ensembl; ENSMUST00000112751; ENSMUSP00000108371; ENSMUSG00000057329. [P10417-1]
Ensembl; ENSMUST00000189999; ENSMUSP00000139856; ENSMUSG00000057329. [P10417-2]
GeneID; 12043; -.
KEGG; mmu:12043; -.
UCSC; uc007cgw.2; mouse. [P10417-1]
CTD; 596; -.
MGI; MGI:88138; Bcl2.
eggNOG; KOG4728; Eukaryota.
eggNOG; ENOG41123S0; LUCA.
GeneTree; ENSGT00530000062935; -.
HOGENOM; HOG000056452; -.
HOVERGEN; HBG004472; -.
InParanoid; P10417; -.
KO; K02161; -.
OrthoDB; EOG091G0OCU; -.
TreeFam; TF315834; -.
Reactome; R-MMU-111447; Activation of BAD and translocation to mitochondria.
Reactome; R-MMU-111453; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members.
Reactome; R-MMU-844455; The NLRP1 inflammasome.
ChiTaRS; Bcl2; mouse.
PRO; PR:P10417; -.
Proteomes; UP000000589; Chromosome 1.
Bgee; ENSMUSG00000057329; Expressed in 258 organ(s), highest expression level in mesenteric lymph node.
CleanEx; MM_BCL2; -.
ExpressionAtlas; P10417; baseline and differential.
Genevisible; P10417; MM.
GO; GO:0005737; C:cytoplasm; IDA:MGI.
GO; GO:0005829; C:cytosol; IDA:MGI.
GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:MGI.
GO; GO:0016020; C:membrane; IDA:MGI.
GO; GO:0031966; C:mitochondrial membrane; IDA:MGI.
GO; GO:0005741; C:mitochondrial outer membrane; ISO:MGI.
GO; GO:0005739; C:mitochondrion; IDA:MGI.
GO; GO:0043209; C:myelin sheath; IDA:MGI.
GO; GO:0031965; C:nuclear membrane; IDA:MGI.
GO; GO:0005654; C:nucleoplasm; ISO:MGI.
GO; GO:0005634; C:nucleus; IDA:MGI.
GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
GO; GO:0046930; C:pore complex; ISO:MGI.
GO; GO:0032991; C:protein-containing complex; ISO:MGI.
GO; GO:0051400; F:BH domain binding; ISO:MGI.
GO; GO:0051434; F:BH3 domain binding; ISO:MGI.
GO; GO:0015267; F:channel activity; ISO:MGI.
GO; GO:0016248; F:channel inhibitor activity; ISO:MGI.
GO; GO:0042802; F:identical protein binding; ISO:MGI.
GO; GO:0002020; F:protease binding; ISO:MGI.
GO; GO:0046982; F:protein heterodimerization activity; IPI:MGI.
GO; GO:0042803; F:protein homodimerization activity; ISO:MGI.
GO; GO:0051721; F:protein phosphatase 2A binding; IDA:MGI.
GO; GO:0019903; F:protein phosphatase binding; IDA:MGI.
GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
GO; GO:0008134; F:transcription factor binding; IPI:MGI.
GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.
GO; GO:0007015; P:actin filament organization; IMP:MGI.
GO; GO:0009887; P:animal organ morphogenesis; IMP:MGI.
GO; GO:0008637; P:apoptotic mitochondrial changes; IDA:MGI.
GO; GO:0006915; P:apoptotic process; IMP:MGI.
GO; GO:0031103; P:axon regeneration; IDA:MGI.
GO; GO:0007409; P:axonogenesis; IMP:MGI.
GO; GO:0030183; P:B cell differentiation; IMP:MGI.
GO; GO:0001782; P:B cell homeostasis; IMP:MGI.
GO; GO:0002326; P:B cell lineage commitment; IMP:MGI.
GO; GO:0042100; P:B cell proliferation; ISO:MGI.
GO; GO:0050853; P:B cell receptor signaling pathway; ISO:MGI.
GO; GO:0001662; P:behavioral fear response; IMP:MGI.
GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IDA:MGI.
GO; GO:0043375; P:CD8-positive, alpha-beta T cell lineage commitment; IMP:MGI.
GO; GO:0007569; P:cell aging; IMP:MGI.
GO; GO:0000902; P:cell morphogenesis; IMP:MGI.
GO; GO:0008283; P:cell proliferation; IGI:MGI.
GO; GO:0098609; P:cell-cell adhesion; IMP:MGI.
GO; GO:0006874; P:cellular calcium ion homeostasis; IDA:MGI.
GO; GO:0006974; P:cellular response to DNA damage stimulus; ISO:MGI.
GO; GO:0042149; P:cellular response to glucose starvation; IDA:MGI.
GO; GO:0071456; P:cellular response to hypoxia; IDA:MGI.
GO; GO:0071310; P:cellular response to organic substance; IDA:MGI.
GO; GO:0021747; P:cochlear nucleus development; IMP:MGI.
GO; GO:0051607; P:defense response to virus; ISO:MGI.
GO; GO:0048589; P:developmental growth; IMP:MGI.
GO; GO:0048066; P:developmental pigmentation; IMP:MGI.
GO; GO:0048546; P:digestive tract morphogenesis; IMP:MGI.
GO; GO:0043583; P:ear development; IMP:MGI.
GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IGI:MGI.
GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IGI:MGI.
GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; ISO:MGI.
GO; GO:0048041; P:focal adhesion assembly; IMP:MGI.
GO; GO:0022612; P:gland morphogenesis; IMP:MGI.
GO; GO:0032835; P:glomerulus development; IMP:MGI.
GO; GO:0031069; P:hair follicle morphogenesis; IMP:UniProtKB.
GO; GO:0030097; P:hemopoiesis; IMP:MGI.
GO; GO:0048873; P:homeostasis of number of cells within a tissue; IMP:MGI.
GO; GO:0002520; P:immune system development; IMP:MGI.
GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IGI:MGI.
GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:MGI.
GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:MGI.
GO; GO:0001822; P:kidney development; IMP:MGI.
GO; GO:0001776; P:leukocyte homeostasis; IMP:MGI.
GO; GO:0002260; P:lymphocyte homeostasis; IMP:MGI.
GO; GO:0002320; P:lymphoid progenitor cell differentiation; IMP:MGI.
GO; GO:0008584; P:male gonad development; IGI:MGI.
GO; GO:0006582; P:melanin metabolic process; IMP:MGI.
GO; GO:0030318; P:melanocyte differentiation; IMP:MGI.
GO; GO:0014031; P:mesenchymal cell development; IMP:MGI.
GO; GO:0001656; P:metanephros development; IMP:MGI.
GO; GO:2000811; P:negative regulation of anoikis; ISO:MGI.
GO; GO:0043066; P:negative regulation of apoptotic process; IDA:MGI.
GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IDA:MGI.
GO; GO:0010507; P:negative regulation of autophagy; IMP:ParkinsonsUK-UCL.
GO; GO:0010523; P:negative regulation of calcium ion transport into cytosol; IGI:MGI.
GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISO:MGI.
GO; GO:0030308; P:negative regulation of cell growth; IMP:MGI.
GO; GO:0030336; P:negative regulation of cell migration; IMP:MGI.
GO; GO:0008285; P:negative regulation of cell proliferation; IMP:MGI.
GO; GO:0032848; P:negative regulation of cellular pH reduction; ISO:MGI.
GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:MGI.
GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:MGI.
GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; ISO:MGI.
GO; GO:0045930; P:negative regulation of mitotic cell cycle; IDA:MGI.
GO; GO:0033033; P:negative regulation of myeloid cell apoptotic process; IDA:MGI.
GO; GO:0043524; P:negative regulation of neuron apoptotic process; IDA:MGI.
GO; GO:0030279; P:negative regulation of ossification; IMP:MGI.
GO; GO:0033689; P:negative regulation of osteoblast proliferation; IMP:MGI.
GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IMP:ParkinsonsUK-UCL.
GO; GO:0046671; P:negative regulation of retinal cell programmed cell death; IMP:MGI.
GO; GO:0051402; P:neuron apoptotic process; IMP:MGI.
GO; GO:0048599; P:oocyte development; IMP:MGI.
GO; GO:0035265; P:organ growth; IMP:MGI.
GO; GO:0001503; P:ossification; IMP:MGI.
GO; GO:0001541; P:ovarian follicle development; IMP:MGI.
GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:MGI.
GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:MGI.
GO; GO:0048753; P:pigment granule organization; IMP:MGI.
GO; GO:0043473; P:pigmentation; IMP:UniProtKB.
GO; GO:0030890; P:positive regulation of B cell proliferation; ISO:MGI.
GO; GO:0043085; P:positive regulation of catalytic activity; IMP:MGI.
GO; GO:0030307; P:positive regulation of cell growth; ISO:MGI.
GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
GO; GO:0048087; P:positive regulation of developmental pigmentation; IMP:MGI.
GO; GO:0045636; P:positive regulation of melanocyte differentiation; IMP:MGI.
GO; GO:0040018; P:positive regulation of multicellular organism growth; IMP:MGI.
GO; GO:0014042; P:positive regulation of neuron maturation; IMP:MGI.
GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IGI:MGI.
GO; GO:0048743; P:positive regulation of skeletal muscle fiber development; IMP:MGI.
GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:MGI.
GO; GO:0009791; P:post-embryonic development; IMP:MGI.
GO; GO:0006470; P:protein dephosphorylation; IDA:MGI.
GO; GO:0000209; P:protein polyubiquitination; ISO:MGI.
GO; GO:0072593; P:reactive oxygen species metabolic process; IMP:MGI.
GO; GO:0042981; P:regulation of apoptotic process; IGI:MGI.
GO; GO:0010506; P:regulation of autophagy; IMP:CACAO.
GO; GO:0051924; P:regulation of calcium ion transport; ISO:MGI.
GO; GO:0050790; P:regulation of catalytic activity; IMP:MGI.
GO; GO:0051726; P:regulation of cell cycle; IMP:MGI.
GO; GO:0001952; P:regulation of cell-matrix adhesion; IMP:MGI.
GO; GO:0048070; P:regulation of developmental pigmentation; IGI:MGI.
GO; GO:0010468; P:regulation of gene expression; IMP:MGI.
GO; GO:0010559; P:regulation of glycoprotein biosynthetic process; IMP:MGI.
GO; GO:0040008; P:regulation of growth; IMP:MGI.
GO; GO:0046902; P:regulation of mitochondrial membrane permeability; IDA:HGNC.
GO; GO:0051881; P:regulation of mitochondrial membrane potential; IDA:HGNC.
GO; GO:0006808; P:regulation of nitrogen utilization; IGI:MGI.
GO; GO:0043067; P:regulation of programmed cell death; IGI:MGI.
GO; GO:0043497; P:regulation of protein heterodimerization activity; ISO:MGI.
GO; GO:0043496; P:regulation of protein homodimerization activity; ISO:MGI.
GO; GO:0032880; P:regulation of protein localization; IMP:MGI.
GO; GO:0031647; P:regulation of protein stability; IMP:MGI.
GO; GO:0022898; P:regulation of transmembrane transporter activity; ISO:MGI.
GO; GO:0045069; P:regulation of viral genome replication; IDA:UniProtKB.
GO; GO:0001836; P:release of cytochrome c from mitochondria; IDA:HGNC.
GO; GO:0003014; P:renal system process; IMP:MGI.
GO; GO:0034097; P:response to cytokine; IMP:MGI.
GO; GO:0042493; P:response to drug; IDA:MGI.
GO; GO:0045471; P:response to ethanol; ISO:MGI.
GO; GO:0010332; P:response to gamma radiation; IMP:MGI.
GO; GO:0051384; P:response to glucocorticoid; IDA:MGI.
GO; GO:0042542; P:response to hydrogen peroxide; IMP:MGI.
GO; GO:0010039; P:response to iron ion; ISO:MGI.
GO; GO:0002931; P:response to ischemia; IMP:MGI.
GO; GO:0035094; P:response to nicotine; ISO:MGI.
GO; GO:0006979; P:response to oxidative stress; IMP:MGI.
GO; GO:0048545; P:response to steroid hormone; IMP:MGI.
GO; GO:0009636; P:response to toxic substance; IMP:MGI.
GO; GO:0010224; P:response to UV-B; IMP:MGI.
GO; GO:0048536; P:spleen development; IMP:MGI.
GO; GO:0030217; P:T cell differentiation; IMP:MGI.
GO; GO:0033077; P:T cell differentiation in thymus; IMP:MGI.
GO; GO:0043029; P:T cell homeostasis; IMP:MGI.
GO; GO:0002360; P:T cell lineage commitment; IMP:MGI.
GO; GO:0048538; P:thymus development; IMP:MGI.
GO; GO:0001657; P:ureteric bud development; IMP:MGI.
Gene3D; 1.10.437.10; -; 1.
InterPro; IPR013278; Apop_reg_Bcl2.
InterPro; IPR002475; Bcl2-like.
InterPro; IPR004725; Bcl2/BclX.
InterPro; IPR020717; Bcl2_BH1_motif_CS.
InterPro; IPR020726; Bcl2_BH2_motif_CS.
InterPro; IPR020728; Bcl2_BH3_motif_CS.
InterPro; IPR003093; Bcl2_BH4.
InterPro; IPR020731; Bcl2_BH4_motif_CS.
InterPro; IPR036834; Blc2-like_sf.
InterPro; IPR026298; Blc2_fam.
PANTHER; PTHR11256; PTHR11256; 1.
PANTHER; PTHR11256:SF11; PTHR11256:SF11; 1.
Pfam; PF00452; Bcl-2; 1.
Pfam; PF02180; BH4; 1.
SMART; SM00265; BH4; 1.
SUPFAM; SSF56854; SSF56854; 1.
TIGRFAMs; TIGR00865; bcl-2; 1.
PROSITE; PS01080; BH1; 1.
PROSITE; PS01258; BH2; 1.
PROSITE; PS01259; BH3; 1.
PROSITE; PS01260; BH4_1; 1.
PROSITE; PS50063; BH4_2; 1.
1: Evidence at protein level;
Alternative splicing; Apoptosis; Complete proteome;
Endoplasmic reticulum; Membrane; Mitochondrion;
Mitochondrion outer membrane; Nucleus; Phosphoprotein;
Reference proteome; Transmembrane; Transmembrane helix;
Ubl conjugation.
CHAIN 1 236 Apoptosis regulator Bcl-2.
TRANSMEM 209 230 Helical. {ECO:0000255}.
MOTIF 10 30 BH4.
MOTIF 90 104 BH3.
MOTIF 133 152 BH1.
MOTIF 184 199 BH2.
SITE 34 35 Cleavage; by caspases. {ECO:0000250}.
MOD_RES 69 69 Phosphothreonine; by MAPK8.
MOD_RES 70 70 Phosphoserine; by MAPK8 and PKC.
MOD_RES 84 84 Phosphoserine; by MAPK8.
GHK -> VGACLVE (in isoform Beta).
MUTAGEN 70 70 S->A: Loss of phosphorylation. Unable to
suppress apoptosis.
CONFLICT 64 64 D -> E (in Ref. 1; AAA37281/AAA37282).
CONFLICT 89 89 V -> C (in Ref. 1; AAA37281/AAA37282).
SEQUENCE 236 AA; 26407 MW; 80FDCFE78C735092 CRC64;

Related products :

Catalog number Product name Quantity
EIAAB29959 Mouse,Mus musculus,Par4,Par-4,Pawr,PRKC apoptosis WT1 regulator protein,Prostate apoptosis response 4 protein
EIAAB29958 Homo sapiens,Human,PAR4,Par-4,PAWR,PRKC apoptosis WT1 regulator protein,Prostate apoptosis response 4 protein
18-003-42147 PRKC apoptosis WT1 regulator protein - Prostate apoptosis response 4 protein; Par-4 Polyclonal 0.05 mg Aff Pur
18-003-42272 PRKC apoptosis WT1 regulator protein - Prostate apoptosis response 4 protein; Par-4 Polyclonal 0.1 mg Protein A
EIAAB29960 Par4,Par-4,Pawr,PRKC apoptosis WT1 regulator protein,Prostate apoptosis response 4 protein,Rat,Rattus norvegicus,Transcriptional repressor Par-4-like protein PAWR
2227 A novel regulator of apoptosis 0.5 mg
CF02 Apoptosis Regulator BAX BAX 500
2227 A novel regulator of apoptosis 0.1 mg
CF02 Apoptosis Regulator BAX BAX lmg
EIAAB05873 CARP1,CARP-1,CCAR1,Cell cycle and apoptosis regulatory protein 1,Cell division cycle and apoptosis regulator protein 1,Death inducer with SAP domain,DIS,Homo sapiens,Human
EIAAB05874 Carp1,CARP-1,Ccar1,Cell cycle and apoptosis regulatory protein 1,Cell division cycle and apoptosis regulator protein 1,Mouse,Mus musculus
ER512 Apoptosis regulator BAX Elisa Kit 96T
18-661-15192 Apoptosis regulator Bcl-2 - N_A Polyclonal 0.1 mg
CSB-EL002573RA Rat Apoptosis regulator BAX(BAX) ELISA kit 96T
EM584 Apoptosis regulator BAX Elisa Kit 96T
3152 (CT) Regulator of mitochondrion apoptosis 0.5 mg
3145 (IN) Regulator of mitochondrion apoptosis 0.5 mg
3147 Regulator of mitochondrion apoptosis 0.5 mg
3151 (CT) Regulator of mitochondrion apoptosis 0.5 mg
3149 (NT) Regulator of mitochondrion apoptosis 0.5 mg
EM454 Apoptosis regulator Bcl-2 Elisa Kit 96T
3145 (IN) Regulator of mitochondrion apoptosis 0.1 mg
3152 (CT) Regulator of mitochondrion apoptosis 0.1 mg
18-003-42867 Apoptosis regulator Bcl-2 - N_A Polyclonal 0.05 mg Aff Pur
CF02 Human Apoptosis Regulator BAX BAX l0


GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur

Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur



9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123

GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

spain@gentaur.com | Gentaur | Gentaur

ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636

GENTAUR Poland Sp. z o.o.

ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556


Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur